Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David O Williams

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|May 4, 2005
The clinical development of percutaneous heart valve technologyThomas A Vassiliades, Peter C Block, Lawrence H Cohn, et al.
The Annals of Thoracic Surgery|April 28, 2005
The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI)Thomas A Vassiliades, Peter C Block, Lawrence H Cohn, et al.
Journal of the American College of Cardiology|May 3, 2005
The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI) Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA)Thomas A Vassiliades, Peter C Block, Lawrence H Cohn, et al.
JACC. Cardiovascular Interventions|May 26, 2009
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trialBernard Chevalier, Carlo Di Mario, Franz-Josef Neumann, et al.
The American Journal of Cardiology|September 22, 2010
Comparison of drug-eluting and bare metal stents for saphenous vein graft lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)Drew E Baldwin, J Dawn Abbott, Jeffrey C Trost, et al.
American Heart Journal|October 8, 2013
Response to Dr Sandar et alJeffrey L Carson, Maria Mori Brooks, J Dawn Abbott, et al.
The New England Journal of Medicine|October 3, 2003
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary arteryJeffrey W Moses, Martin B Leon, Jeffrey J Popma, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Temporal trends in patient-reported angina at 1 year after percutaneous coronary revascularization in the stent era: a report from the National Heart, Lung, and Blood Institute-sponsored 1997-2006 dynamic registryLakshmi Venkitachalam, Kevin E Kip, Suresh R Mulukutla, et al.
Journal of the American College of Cardiology|July 10, 2007
Thrombosis and drug-eluting stents: an objective appraisalDavid R Holmes, Dean J Kereiakes, Warren K Laskey, et al.
The American Journal of Cardiology|December 6, 2012
Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registrySuresh R Mulukutla, Oscar C Marroquin, Helen A Vlachos, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Thoracic and Cardiovascular Surgery|May 4, 2005
The clinical development of percutaneous heart valve technologyThomas A Vassiliades, Peter C Block, Lawrence H Cohn, et al.
The Annals of Thoracic Surgery|April 28, 2005
The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI)Thomas A Vassiliades, Peter C Block, Lawrence H Cohn, et al.
Journal of the American College of Cardiology|May 3, 2005
The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI) Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA)Thomas A Vassiliades, Peter C Block, Lawrence H Cohn, et al.
JACC. Cardiovascular Interventions|May 26, 2009
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trialBernard Chevalier, Carlo Di Mario, Franz-Josef Neumann, et al.
The American Journal of Cardiology|September 22, 2010
Comparison of drug-eluting and bare metal stents for saphenous vein graft lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)Drew E Baldwin, J Dawn Abbott, Jeffrey C Trost, et al.
American Heart Journal|October 8, 2013
Response to Dr Sandar et alJeffrey L Carson, Maria Mori Brooks, J Dawn Abbott, et al.
The New England Journal of Medicine|October 3, 2003
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary arteryJeffrey W Moses, Martin B Leon, Jeffrey J Popma, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Temporal trends in patient-reported angina at 1 year after percutaneous coronary revascularization in the stent era: a report from the National Heart, Lung, and Blood Institute-sponsored 1997-2006 dynamic registryLakshmi Venkitachalam, Kevin E Kip, Suresh R Mulukutla, et al.
Journal of the American College of Cardiology|July 10, 2007
Thrombosis and drug-eluting stents: an objective appraisalDavid R Holmes, Dean J Kereiakes, Warren K Laskey, et al.
The American Journal of Cardiology|December 6, 2012
Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registrySuresh R Mulukutla, Oscar C Marroquin, Helen A Vlachos, et al.
Pageof 12